Skip to main content

Gefäßalterung

Die Rolle von oxidativem Stress und Proteinglykierung

Vessel aging

The role of oxidative stress and protein glycation

Zusammenfassung

Langsam ablaufende primäre Alterungsmechanismen führen zu anfangs unbemerkten Veränderungen im Gefäßsystem. Die endotheliale Dysfunktion ist ein früher Marker der Gefäßalterung. Ursache ist oxidativer Stress, der einerseits durch eine Reduktion der Bioverfügbarkeit von Stickstoffmonoxid (NO) und andererseits durch die Nitrosylierung wichtiger zellulärer Proteine vermittelt wird. Parallel dazu kommt es durch die Glykierung der extrazellulären Matrix zur Versteifung der Gefäße. In Kombination mit dem Verlust der elastischen Fasern wie Elastin führen diese Komponenten zu altersbedingten Gefäßveränderungen. Das Verständnis der Wirkung primärer Alterungsmechanismen könnte die Basis für die Entwicklung neuer Medikamente bilden.

Abstract

The slow procession of the primary mechanisms of aging lead, at first, to unnoticed changes in the vascular system. Endothelial dysfunction is one of the earliest markers in aging vessels, caused by oxidative stress via the reduction of the availability of NO, on the one hand, and the nitrosylation of proteins, on the other hand. At the same time, glycation of the proteins of the extracellular matrix leads to stiffening of the vessel wall. Together with the loss of elastic fibers, e.g., elastin, this leads to the age-related changes of the vessels. Knowledge of these primary mechanisms of aging may lead to the development of new drugs.

This is a preview of subscription content, access via your institution.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Oeppen J, Vaupel JW (2002) Demography. Broken limits to life expectancy. Science 296:1029–1031

    PubMed  Article  CAS  Google Scholar 

  2. Lakatta EG, Levy D (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: Aging arteries: a „set up“ for vascular disease. Circulation 107:139–146

    PubMed  Article  Google Scholar 

  3. Küng CF, Lüscher TF (1995) Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 25:194–200

    PubMed  Google Scholar 

  4. Shin D, Pregenzer G Jr, Gardin JM (2011) Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev 19:5–11

    PubMed  Article  Google Scholar 

  5. Ozaki K, Hori T, Ishibashi T et al (2010) Effects of chronic cigarette smoking on endothelial function in young men. J Cardiol 56:307–313

    PubMed  Article  Google Scholar 

  6. Simm A, Nass N, Bartling B et al (2008) Potential biomarkers of ageing. Biol Chem 389:257–265

    PubMed  Article  CAS  Google Scholar 

  7. Castle SC (2000) Impact of age-related immune dysfunction on risk of infections. Z Gerontol Geriatr 33:341–349

    PubMed  Article  CAS  Google Scholar 

  8. Franceschi C, Capri M, Monti D et al (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92–105

    PubMed  Article  CAS  Google Scholar 

  9. Bruunsgaard H, Pedersen BK (2003) Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 23:15–39

    PubMed  Article  Google Scholar 

  10. Koenig W, Khuseyinova N, Baumert J et al (2006) Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Arterioscler Thromb Vasc Biol 26:2745–2751

    PubMed  Article  CAS  Google Scholar 

  11. Corpas E, Harman SM, Blackman MR (1993) Human growth hormone and human aging. Endocr Rev 14:20–39

    PubMed  CAS  Google Scholar 

  12. Chahal HS, Drake WM (2007) The endocrine system and ageing. J Pathol 211:173–180

    PubMed  Article  CAS  Google Scholar 

  13. Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614–636

    PubMed  Article  CAS  Google Scholar 

  14. Dimri GP, Lee X, Basile G et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363–9367

    PubMed  Article  CAS  Google Scholar 

  15. Zglinicki Tvon, Martin-Ruiz CM (2005) Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med 5:197–203

    Article  Google Scholar 

  16. Mimeault M, Batra SK (2010) Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies. J Cell Mol Med 14:116–134

    PubMed  Article  CAS  Google Scholar 

  17. Erusalimsky JD (2009) Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol 106:326–332

    PubMed  Article  CAS  Google Scholar 

  18. Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol Nurs 11:298–300

    CAS  Google Scholar 

  19. Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120:483–495

    PubMed  Article  CAS  Google Scholar 

  20. Landis GN, Tower J (2005) Superoxide dismutase evolution and life span regulation. Mech Ageing Dev 126:365–379

    PubMed  Article  CAS  Google Scholar 

  21. Willcox BJ, Curb JD, Rodriguez BL (2008) Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. Am J Cardiol 101:75D–86D

    PubMed  Article  CAS  Google Scholar 

  22. Nass N, Bartling B, Navarrete Santos A et al (2007) Advanced glycation end products, diabetes and ageing. Z Gerontol Geriatr 40:349–56

    PubMed  Article  CAS  Google Scholar 

  23. Bartling B, Desole M, Rohrbach S et al (2009) Age-associated changes of extracellular matrix collagen impair lung cancer cell migration. FASEB J 23:1510–1520

    PubMed  Article  CAS  Google Scholar 

  24. Münch G, Schicktanz D, Behme A et al (1999) Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library. Nat Biotechnol 17:1006–1010

    PubMed  Article  Google Scholar 

  25. Loo B van der, Koppensteiner R, Lüscher TF (2004) How do blood vessels age? Mechanisms and clinical implications. Vasa 33:3–11

    PubMed  Google Scholar 

  26. Espinola-Klein C, Münzel T (2008) Oxidativer Stress und Endothelfunktion: Welche Bedeutung hat das Geschlecht? Blickpunkt der Mann 6(4):29–31

    Google Scholar 

  27. Wolffenbuttel BH, Boulanger CM, Crijns FR et al (1998) Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95:4630–4634

    PubMed  Article  CAS  Google Scholar 

  28. Paravicini TM, Touyz RM (2006) Redox signaling in hypertension. Cardiovasc Res 71:247–258

    PubMed  Article  CAS  Google Scholar 

  29. Gielen S, Schuler G, Adams V (2010) Cardiovascular effects of exercise training: molecular mechanisms. Circulation 122:1221–1238

    PubMed  Article  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Affiliations

Authors

Corresponding author

Correspondence to A. Simm.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Simm, A. Gefäßalterung. Z Gerontol Geriat 44, 146–152 (2011). https://doi.org/10.1007/s00391-011-0200-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00391-011-0200-7

Schlüsselwörter

  • Altern
  • Reaktive Sauerstoffspezies
  • Oxidativer Stress
  • „Advanced glycation end products“
  • Endotheliale Dysfunktion

Keywords

  • Aging
  • Reactive oxygen species
  • Oxidative stress
  • Advanced glycation end products
  • Endothelial dysfunction